Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification
Authors:
- 24 July 2006
- journal article
- review article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 41 (6) , 513-523
Abstract
Although placebo response rates in clinical trials for functional dyspepsia (FD) are more than 30%, a recent meta-analysis based on randomized controlled trials (RCTs) showed that antisecretory drugs were more or less superior to placebos. On the other hand, large-scale RCTs on the efficacy of treatment with prokinetics on FD are still needed. Indications for antibiotic eradication therapy for Helicobacter pylori-positive FD are still controversial, but there seems to be a small but significant therapeutic gain achieved with H. pylori eradication. Since preprandial and postprandial symptomatic disturbances are very important targets for FD treatment, ghrelin, a novel appetite-promoting gastrointestinal peptide that also promotes gastric motility or basal acid secretion can be expected to be a therapeutic target. In the recently published Rome III classification, FD is redefined for patients with symptoms thought to originate from the gastroduodenal region, specifically epigastric pain or burning, postprandial fullness, or early satiation, and it is divided into the subcategories postprandial distress syndrome and epigastric pain syndrome. These new criteria are of value in clinical practice, for epidemiological, pathophysiological, and clinical research, and for the development of new therapeutic strategies.Keywords
This publication has 78 references indexed in Scilit:
- Predictors of the placebo response in functional dyspepsiaAlimentary Pharmacology & Therapeutics, 2006
- Emotional Stress Enhanced Ghrelin Secretion from the StomachJournal of Clinical Biochemistry and Nutrition, 2006
- The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptomsJournal of Gastroenterology, 2005
- Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic reviewJournal of Gastroenterology, 2005
- Influence of ghrelin on interdigestive gastrointestinal motility in humansGut, 2005
- Prevalence of acid reflux in functional dyspepsia and its association with symptom profileGut, 2005
- Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbilsGut, 2004
- DyspepsiaAnnals of Internal Medicine, 2001
- Absence of Benefit of EradicatingHelicobacter pyloriin Patients with Nonulcer DyspepsiaNew England Journal of Medicine, 1999
- Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy.Gut, 1995